The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


PRANDIN

0.5 Milligram Tablets

Novo Nordisk A/SEU/1/00/162/003

Main Information

Trade NamePRANDIN
Active SubstancesREPAGLINIDE
Strength0.5 Milligram
Dosage FormTablets
Licence HolderNovo Nordisk A/S
Licence NumberEU/1/00/162/003

Group Information

ATC CodeA10BX02 repaglinide

Status

Authorised/WithdrawnAuthorised
Licence Issued29/01/2001
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back